The increasing prevalence of disorders, such as cancer, cardiovascular disorders, autoimmune disorders, and health problems, has created the need for advanced and efficient in-vitro diagnostics and monitoring of disorders which helps in the treatment. As per the National Stem Cell Foundation (NSCF) 2022 report, ~4% of the world’s population was affected by 1 among over 80 different autoimmune diseases. It affects 5–8% of the total population in the US alone. This is driving the growth of the IVD contract research organization market. Clinical trials play a critical role in evaluating the safety and effectiveness of drugs or devices for commercial usage. These studies help understand the best possible approaches for diagnostics and therapeutic areas. The increased prevalence of disorders has created the demand for advanced IVD diagnostics, which fueled the clinical trial promoting the growth of the IVD contract research organization market.
Furthermore, increased research & development activities and the rising investment in the development of IVD diagnostics have increased the adoption of outsourcing activities. The rising adoption of outsourcing in drug or device development services is time-saving and cost-effective. This has led to an increase in contract research organizations to support manufacturers in developing advanced IVD diagnostics. For instance, it is expected that by 2022, there will be 4,250 contract research organizations businesses in the US. Thus, an increasing prevalence of disorders and clinical trials and a surge in R&D investments and contract research organizations are driving the growth of the IVD contract research organization market.
Strategic insights for the North America IVD Contract Research Organization provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 1,882.10 Million |
Market Size by 2028 | US$ 3,213.78 Million |
Global CAGR (2021 - 2028) | 7.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America IVD Contract Research Organization refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
North America IVD Contract Research Organization Market Segmentation
The North America IVD contract research organization market is analyzed on the basis of type, services, and country. By type, the market is segmented into clinical chemistry, molecular diagnostics, immunochemistry, companion diagnostics, hematology, histology and cytology, microbiology, and others. The clinical chemistry segment held the largest share of the market in 2020. By services, the market is segmented into clinical research, biostatistics and data management services, therapeutic expertise, regulatory services, reimbursement services, assay development services, and others. The biostatistics and data management services segment held the largest share of the market in 2020.
Based on country, the North America IVD contract research organization market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2020.
CMIC HOLDINGS CO., LTD; DCN Dx; ICON PLC; NAMSA; Nexelis, a Q² Solutions Company; Proxima Clinical Research, Inc.; ResearchDx; and Toolbox Medical Innovations are the leading companies in the North America IVD contract research organization market.
The North America IVD Contract Research Organization Market is valued at US$ 1,882.10 Million in 2021, it is projected to reach US$ 3,213.78 Million by 2028.
As per our report North America IVD Contract Research Organization Market, the market size is valued at US$ 1,882.10 Million in 2021, projecting it to reach US$ 3,213.78 Million by 2028. This translates to a CAGR of approximately 7.9% during the forecast period.
The North America IVD Contract Research Organization Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America IVD Contract Research Organization Market report:
The North America IVD Contract Research Organization Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America IVD Contract Research Organization Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America IVD Contract Research Organization Market value chain can benefit from the information contained in a comprehensive market report.